Cargando…
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
SIMPLE SUMMARY: Diffuse intrinsic pontine glioma (DIPG) is a malignant primary glial tumor that occurs in all age groups but predominates in children and is estimated to account for approximately 10–15% of pediatric brain tumors. The median age at diagnosis was 6–7 years, and the median survival of...
Autores principales: | Chen, Yujia, Zhao, Chao, Li, Shenglun, Wang, Jun, Zhang, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913210/ https://www.ncbi.nlm.nih.gov/pubmed/36765560 http://dx.doi.org/10.3390/cancers15030602 |
Ejemplares similares
-
Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
por: Lin, Grant L., et al.
Publicado: (2018) -
Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma
por: Bredlau, Amy Lee, et al.
Publicado: (2017) -
Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
por: Liu, Guohao, et al.
Publicado: (2022) -
Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma
por: Wang, Jun, et al.
Publicado: (2023) -
Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma
por: HASHIZUME, Rintaro
Publicado: (2017)